newsfilter
← Latest News
PR Newswire·

A joint patent application for MALT1 inhibitors published

STOCKHOLM, Oct. 15, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that a joint patent application for MALT1 inhibitors submitted together with Rheos Medicines, Inc., a US-based biopharmaceutical company, has been made public.